News

Canada Adopts First-Ever Rare Disease Strategy


 

References

Canada has adopted its first-ever nationwide Rare Disease Strategy with five key goals to improve care and treatment of rare disorders. The goals are: improving early detection and prevention, providing better care, enhancing community support, providing access to promising therapies, and promoting innovative research. Read the executive summary provided by the Canadian Organization for Rare Disorders (CORD).

http://www.raredisorders.ca/documents/WEBENFinalExecSummaryMay232015.pdf


Recommended Reading

NORD to honor NIH Director and others at Portraits of Courage Celebration
MDedge Pediatrics
NORD urges Congress to support development of treatments for rare pediatric diseases
MDedge Pediatrics
How to code for cystic fibrosis–related diabetes
MDedge Pediatrics
Cystic fibrosis–related diabetes requires different approach
MDedge Pediatrics
FDA panel supports approval of combination drug for cystic fibrosis
MDedge Pediatrics
Augmenting therapy boosts event-free survival in high-risk Wilms tumor
MDedge Pediatrics
Bill to speed FDA approvals includes rewards for drugs designed for kids
MDedge Pediatrics
NORD Issues Statement on Approval of 21st Century Cures Initiative and Introduction of OPEN Act
MDedge Pediatrics
Foundation for Prader-Willi Research and NORD Launch Global Registry
MDedge Pediatrics
NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)
MDedge Pediatrics